Breast Cancer Clinical Trial
Official title:
Spousal Relationships and Pain in Metastatic Breast Cancer
Ecological Momentary Assessment (EMA) refers to the collection of repeated measurements of
phenomena as they occur in naturalistic settings using hand-held computers. By providing an
EMA of psychosocial variables that influence patient pain and pain behaviors, this study
seeks to characterize the pain experience in metastatic breast cancer from both patients'
and spouses' perspectives.
This study consists of two parts. Part 1 involves developing and pilot testing a hand-held
computer program designed to assess antecedents, behaviors, and consequences of patient
pain, as well as spouse response to pain. Five couples will complete a baseline survey and
carry the hand-held computer for two weeks. They will be interviewed for feedback to refine
the program. Part 2 is a longitudinal assessment of the psychological and relationship
functioning of metastatic breast cancer patients and their spouses. The Optional Procedure
for Part 2 involves using electronic diaries (EDs) to measure the cancer pain experience for
patients with metastatic breast cancer and their spouses.
The specific aims of this study are to: (1) To examine patient pain, spouse response to
patient pain, and patient behaviors in response to pain over the course of 6 months in
couples facing metastatic breast cancer, (2) test the biopsychosocial model of chronic pain
in breast cancer; expanding it to include the influence of patient psychological
functioning, spouse psychological functioning, and relationship functioning, on patient
pain, spouse behaviors, and patient behaviors in response to pain, (3) use ecological
momentary assessment to characterize patient pain, spouse response to patient pain, and
patient behaviors in response to pain.
| Status | Completed |
| Enrollment | 548 |
| Est. completion date | |
| Est. primary completion date | July 2015 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Both |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria: 1. For Patients: Being a female patient diagnosed with metastatic breast cancer. 2. For Patients: Initiating treatment for metastatic breast cancer 3. For Patients: Having and ECOG Performance Status Score of 2 or less 4. For Spouses: Being the male spouse or significant other of a female patient diagnosed with metastatic breast cancer 5. For Spouses: Having the patient's consent to be contacted 6. For Patients and Spouses: Having the ability to read and speak English well enough to understand the consent form and complete the questionnaires 7. For Patients and Spouses: Being able to provide informed consent Exclusion Criteria: 1. For Patients and Spouses: Not being able to provide informed consent. 2. For Patients: Rating average pain as 0 on the BPI |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Texas MD Anderson Cancer Center | Houston | Texas |
| Lead Sponsor | Collaborator |
|---|---|
| M.D. Anderson Cancer Center | United States Department of Defense |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Longitudinal assessment of the psychological and relationship functioning of metastatic breast cancer patients and their spouses. | 6 Months | No | |
| Secondary | Pilot of hand-held computers at home for metastatic breast cancer patient and spouses to answer questions about pain and other symptoms. | 14 Days (Survey Response + 30 Minute Interview) | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
| Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
| Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
| Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
| Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
| Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
| Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
| Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
| Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
| Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
| Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
| Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
| Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
| Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
| Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
| Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
| Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A |